Article
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
RMD Open
(2018)
Disciplines
Publication Date
March 1, 2018
DOI
10.1136/rmdopen-2017-000582
Citation Information
Désirée van der Heijde, Atul Deodhar, Oliver FitzGerald, Roy Fleischmann, et al.. "4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis" RMD Open Vol. 4 Iss. 1 (2018) Available at: http://works.bepress.com/philip-mease/17/